companydata.dkACUPHARMA ApS: Financial statements 2023
CVR: 10072956
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,128,195 and a net result of DKK 153,246 compared with DKK -449,629 the year before. That is an increase of 44.9% compared with the year before. Equity amounted to DKK -138,107. The company had 2 employees in the financial year.
- Gross Profit
- 1,128,195 kr.
- Profit/Loss
- 153,246 kr.
- Equity
- -138,107 kr.
- Total Assets
- 2,103,498 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.1 mio. | 153 t. | -138 t. | 2 |
| 2022 | - | 778 t. | -450 t. | -291 t. | 2 |
| 2021 | - | 1.2 mio. | 6 t. | 158 t. | 3 |
| 2020 | - | 1.4 mio. | -235 t. | 152 t. | 3 |
| 2019 | - | 1.7 mio. | 33 t. | 387 t. | 4 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ACUPHARMA ApS has published its annual report for 2022. Gross profit came to DKK 778,365, and the net result was DKK -449,629.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees. In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity amounted to DKK -109,301.